Sign in

CIK 0001326110

  • Large accelerated filer

ImmunityBio, Inc.

Sign in to watch
Ticker
IBRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
431979754
Phone
+1 844-696-5235
Business address
3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
Former names
NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,119,848
in 2 filings, $1.1M under 10b5-1 plans

Net −$1,119,848. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Cohen Cheryl −$851K Director sold 45% of stake
  2. Simon Barry J. −$269K Director sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2026-02-22 Sachs David C. Chief Financial Officer Option exercise +40,650 320,825
2026-02-22 Sachs David C. Chief Financial Officer Shares withheld for taxes −20,682 $8.70 $180K 300,143
2026-02-22 Sachs David C. Chief Financial Officer Option exercise · Restricted Stock Units −40,650 40,651
2026-02-10 Sachs David C. Chief Financial Officer Option exercise +82,236 322,818
2026-02-10 Sachs David C. Chief Financial Officer Shares withheld for taxes −42,643 $6.93 $296K 280,175
2026-02-10 Sachs David C. Chief Financial Officer Option exercise · Restricted Stock Units −82,236 164,474
2025-12-31 Sachs David C. Chief Financial Officer Option exercise +30,397 256,017
2025-12-31 Sachs David C. Chief Financial Officer Shares withheld for taxes −15,435 $1.98 $31K 240,582
2025-12-31 Sachs David C. Chief Financial Officer Option exercise · Restricted Stock Units −30,397 45,602
2025-02-22 Sachs David C. Chief Financial Officer Option exercise +40,650 241,480
2025-02-22 Sachs David C. Chief Financial Officer Shares withheld for taxes −15,860 $3.42 $54K 225,620
2025-02-22 Sachs David C. Chief Financial Officer Option exercise · Restricted Stock Units −40,650 81,301
2025-02-10 Sachs David C. Chief Financial Officer Grant or award · Restricted Stock Units +246,710 246,710
2025-02-10 Sachs David C. Chief Financial Officer Grant or award · Stock Option (right to buy) +843,750 843,750
2024-12-31 Sachs David C. Chief Financial Officer Option exercise +30,397 216,235
2024-12-31 Sachs David C. Chief Financial Officer Shares withheld for taxes −15,405 $2.56 $39K 200,830
2024-12-31 Sachs David C. Chief Financial Officer Option exercise · Restricted Stock Units −30,397 75,999
2024-02-22 Sachs David C. Chief Financial Officer Grant or award · Restricted Stock Units +121,951 121,951
2024-02-22 Sachs David C. Chief Financial Officer Grant or award · Stock Option (right to buy) +424,390 424,390
2024-01-31 Sachs David C. Chief Financial Officer Option exercise +70,745 212,673

Page 1 of 2 · 36 trades